Réada Cronin (Kildare North, Sinn Fein)
Link to this: Individually | In context | Oireachtas source

470. To ask the Minister for Health if he will introduce antigen Covid-19 testing and screening for schools; and if he will make a statement on the matter. [3471/21]

Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

There is ongoing consideration given by the Government to policy in relation to the management of Covid-19 in school settings.

The Health Protection Surveillance Centre has published Guidance for Educational Settings relating to the management of Covid-19 in school settings. This guidance, which includes protocols relating to the management of close contacts, is available at

The Deputy may wish to note that schools must have a Covid-19 Response Plan and a Covid policy in place. Up-to-date Government advice and resources for schools, parents and students in the context of COVID-19, including advice on Covid-19 planning is published at

.

Where a school is informed of a pupil or staff member who has tested positive for Covid-19, if the case was in the school during the infectious period, the HSE endeavour to contact school management the same day, although this may be the following day in some cases. When public health doctors make contact with the school, they will proceed to undertake a Public Health Risk Assessment (PHRA). Core to the PHRA will be assessing the likelihood of onward transmission from the case identified, and this will inform their further actions. The risk assessment applied in school settings may be dynamic and change as new information becomes available, and the testing strategy may evolve as information unfolds.

The Health Service Executive has adopted RNA PCR as the gold standard test for diagnosing Covid-19 cases, as part of the HSE test and trace strategy, consistent with international best practice, and approved by the National Public Health Emergency Team (NPHET). This platform is deployed in acute hospitals, the NVRL and HSE’s commercial partners.

It should be noted that testing for Sars-Cov2 does not confirm that an individual with a 'not detected' result is not incubating the infection or the level of virus is below detectable levels at the time of the test. The HSE has worked intensively over the last number of months to put in place a comprehensive testing and tracing operation and despite the very significant increase in demand over the last number of weeks, the median time for community referral to appointment is 0.8 days with 92.5% of GP referrals provided with a COVID-19 test appointment within 24 hours. While the automatic referral of close contacts for testing is generally paused on a temporary basis, close contacts in outbreak and school settings continue to be referred for a test.

While rapid antigen diagnostic tests (RADTs) are described as rapid, and simple to perform, they are not designed to be delivered in large numbers. RADTs are most effective in detection of symptomatic cases, particularly where there is swabbing capacity on-site, when symptom onset is within the last 5 days and when the likelihood of test positivity is greater than 10% among the target population. Validation studies, both here in Ireland and in Europe are showing significant disparities in sensitivity and specificity of tests versus manufacturer claims. The studies also show that performance in symptomatic patients is much better than in asymptomatic patients. In asymptomatic patients, sensitivity results are being shown to be below the minimum performance requirements set by the World Health Organization and the European Centre for Disease Prevention and Control.

The National Public Health Emergency Team has endorsed recommendations on the use of Rapid Antigen Detection Tests (RADTs) as a supplement to PCR testing in certain situations, and particularly when the availability of PCR tests may be limited. The HSE is currently considering the use of RADTs for diagnosis of symptomatic persons and their close contacts in PCR confirmed outbreaks, and / or symptomatic persons where there is a high suspicion of an outbreak, pending PCR confirmation, if faster presumptive results will inform public health action.

On an ongoing basis, NPHET considers and reviews, based on public health risk assessments, how best to target testing to hunt the virus in populations where it’s most likely and where it will do most harm. This includes keeping Ireland’s testing policy under continuing review.